WEEKLY NEWSLETTER
Memantine for Alzheimer's disease
Examples
| Generic Name | Brand Name |
|---|---|
| memantine hydrochloride | Namenda |
How It Works
Memantine is the first of a new class of medications developed to treat Alzheimer's disease. It has been available in Europe for years but was only recently approved for treating Alzheimer's disease in the United States. It works in a completely different way compared to other Alzheimer's disease medications.
It is possible that symptoms of Alzheimer's disease may be related to an imbalance of brain chemicals—specifically glutamate—that affect learning and memory. Memantine blocks the activity of glutamate and improves moderate to severe symptoms of Alzheimer's disease.1
Why It Is Used
Memantine is the first medication available that slows the late stages of Alzheimer's disease. It effectively reduces moderate to severe symptoms of memory loss and thinking problems, as opposed to other medications that improve mild to moderate symptoms.2
How Well It Works
Memantine is the only medication available to treat more severe thinking and memory symptoms of Alzheimer's disease. However, no medication has yet been developed that can stop the damaging changes in the brain that cause personality changes and memory loss from Alzheimer's disease.
Patients with moderate to severe Alzheimer's disease who were taking cholinesterase inhibitors experienced improvement in their thinking and daily functioning when they added memantine (Namenda) to their treatment.3
Side Effects
Common mild side effects include:3
- Dizziness.
- Confusion.
- Headache.
- Constipation.
People who have severe kidney disease may not be able to take memantine and those with moderate kidney disease may need to take smaller doses.
See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)
What To Think About
If current medications have not helped, you may want to talk with the person's doctor about trying memantine. Other medications may reduce mild to moderate symptoms, but memantine has been shown to reduce moderate to severe symptoms of thinking and memory problems from Alzheimer's disease.
Memantine, like other Alzheimer's disease medications, will not stop the progression of the disease.
Complete the
new medication information form (PDF)
(What is a PDF document?)
to help you understand this medication.
References
Citations
Memantine for Alzheimer's disease (2003). Medical Letter on Drugs and Therapeutics, 45(W1165A): 73–74.
Areosa Sastre A, et al. (2006). Memantine for dementia. Cochrane Database of Systematic Reviews (1). Oxford: Update Software.
Tariot PN, et al. (2004). Memantine treatment in patients with moderate to severe Alzheimer's disease already receiving donepezil. JAMA, 291(3): 317–324.
Last Updated:
November 15, 2006- Author:
- Sabra L. Katz-Wise
Ralph Poore - Medical Review:
- Adam Husney, MD - Family Medicine
Kathleen Romito, MD - Family Medicine
Peter J. Whitehouse, MD - Neurology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
